Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
儿童疫苗对预防 1 型糖尿病、自身免疫性甲状腺疾病和乳糜泻的有益作用
基本信息
- 批准号:10482378
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-06 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAutoantibodiesAutoimmune DiseasesAutoimmunityCOVID-19 pandemicCeliac DiseaseChildChildhoodChildhood diabetesChronicChronic DiseaseClinical TrialsComplexConduct Clinical TrialsCongenital Rubella SyndromeDataData SetDatabasesDiabetes MellitusDigestive System DisordersDiseaseEnrollmentEnsureEpidemiologyFamiliarityGoalsHashimoto DiseaseHealth InsuranceImmune responseImmunityImmunizationIncidenceInfantInfectionInsulin-Dependent Diabetes MellitusInsuranceInsurance CoverageIslet CellIslets of LangerhansKidney DiseasesKnowledgeLaboratoriesMeaslesMeasles VaccineMeasles-Mumps-Rubella VaccineMediatingMolecular MimicryMumpsNatural ImmunityObesityObservational StudyParentsPersonsPharmaceutical PreparationsPopulationPreventionPreventive measureProductionReportingRiskRotavirusRotavirus InfectionsRotavirus VaccinesRubellaStatistical Data InterpretationStructure of beta Cell of isletT cell responseT memory cellT-Lymphocyte EpitopesTestingThyroglobulin antibodyTrainingUnited StatesVaccinatedVaccinationVaccinesVirus DiseasesVisitWorkautoimmune thyroid diseasedisorder preventionearly childhoodhigh risklarge datasetspreventprotective effectresponserisk minimizationsafety studysecondary analysisstemunethicalunvaccinatedvaccine hesitancyvaccine refusalvaccine safetyvaccine trial
项目摘要
Viral infections have long been hypothesized to be triggers for childhood autoimmune conditions, but the
benefit of childhood vaccines for prevention of such diseases is uncertain. Studies focusing upon such benefits
are critical due to the rising rates of vaccine deferral in the U.S and the lowered rates of pediatric vaccination
due to the COVID pandemic.
This is a resubmission for
PA-18741 R21 Secondary Analyses in Obesity,
Diabetes and Digestive and Kidney Diseases. Our goal is to examine whether measles, mumps, and rubella
vaccine (MMR) and rotavirus vaccine (RV) protect children from developing 3 associated autoimmune
diseases during childhood: type 1 diabetes (T1D), celiac disease, and autoimmune thyroid disease. Congenital
rubella increases pancreatic islet cell autoantibody production, and we and others have reported that
congenital rubella infection increases risk for T1D. Congenital rubella infection is also associated with anti-
thyroglobulin antibody, a precursor of autoimmune thyroid disease. MMR appears to induce heterologous as
well as trained T-cell responses, thus conferring immunity that is polymicrobial as well as protection against
measles, mumps, and rubella. Therefore, MMR may plausibly protect against triggers for autoimmune disease,
but existing studies are relatively few and underpowered. Along similar lines, we and others have reported that
RV protects against T1D, possibly by interfering with auto-immunization caused by molecular mimicry. Among
persons at high risk for T1D, RV also protects against childhood celiac disease. It is uncertain whether RV
protects against celiac disease in a broad population, and whether RV protects against autoimmune thyroid
disease. To address these knowledge gaps, we propose to examine the protective effects of MMR for
childhood T1D, celiac disease, and autoimmune thyroid disease as well as RV for celiac disease and
autoimmune thyroid disease in the national, longitudinally-integrated health insurance database that we used
in our previous studies (n=1,474,535). Aim 1 is to examine whether MMR decreases risk of early childhood
T1D; we hypothesize that infants who receive MMR will have lower risk compared to unvaccinated infants. Aim
2 is to examine whether MMR and RV decrease risk of early childhood celiac disease. We hypothesize that
infants who receive MMR or RV will have lower risk compared to unvaccinated infants. Aim 3 is to examine
whether MMR and RV decrease risk of early childhood autoimmune thyroid disease. We hypothesize that
infants who receive MMR or RV will have lower risk compared to unvaccinated infants. It is unethical to
conduct clinical trials to establish the impact of vaccines upon autoimmune disease, but studies focusing upon
autoimmune disease prevention are under-powered. Therefore, carefully conducted observational studies are
needed which examine the benefits of vaccines for such diseases. Such benefits may prove to be a compelling
motivator to vaccinate for the vaccine-hesitant. Due to our expertise in epidemiology, statistical analysis of
complex relational data, and familiarity with the datasets, we can efficiently conduct this high-impact work.
长期以来,病毒感染一直被假设为儿童自身免疫性疾病的触发因素,
儿童疫苗对预防这类疾病的益处尚不确定。以这些益处为重点的研究
由于美国疫苗推迟接种率的上升和儿科疫苗接种率的下降,
因为新冠疫情
这是一个重新提交的,
PA-18741 R21肥胖的次要分析,
糖尿病、消化系统和肾脏疾病。我们的目标是检查麻疹腮腺炎和风疹
MMR疫苗和轮状病毒疫苗可保护儿童免于发生3种相关的自身免疫性疾病
儿童时期的疾病:1型糖尿病(T1 D)、乳糜泻和自身免疫性甲状腺疾病。先天性
风疹增加胰岛细胞自身抗体的产生,我们和其他人报道,
先天性风疹感染会增加T1 D的风险。先天性风疹感染也与抗-
甲状腺球蛋白抗体,自身免疫性甲状腺疾病的前兆。MMR似乎诱导异源,
以及训练有素的T细胞反应,从而赋予免疫力,这是多微生物以及保护免受
麻疹、腮腺炎和风疹。因此,MMR可能可以保护自身免疫性疾病的触发因素,
但现有的研究相对较少且力度不足。沿着类似的路线,我们和其他人报告说,
RV可能通过干扰分子模拟引起的自身免疫来保护T1 D。之间
对于T1 D高危人群,RV还可预防儿童乳糜泻。不确定RV是否
在广泛人群中预防乳糜泻,以及RV是否能预防自身免疫性甲状腺疾病
疾病为了解决这些知识空白,我们建议检查MMR的保护作用,
儿童T1 D、乳糜泻和自身免疫性甲状腺疾病以及RV乳糜泻,
自身免疫性甲状腺疾病在国家,医疗综合健康保险数据库,我们使用
在我们之前的研究中(n= 1,474,535)。目标1是检查MMR是否可以降低幼儿期的风险
T1 D;我们假设接受MMR的婴儿与未接种疫苗的婴儿相比风险较低。目的
2是检查MMR和RV是否降低儿童早期乳糜泻的风险。我们假设
与未接种疫苗的婴儿相比,接种MMR或RV的婴儿风险较低。目标3:检查
MMR和RV是否降低儿童早期自身免疫性甲状腺疾病的风险。我们假设
与未接种疫苗的婴儿相比,接种MMR或RV的婴儿风险较低。是不道德
进行临床试验,以确定疫苗对自身免疫性疾病的影响,但研究的重点是
自身免疫性疾病的预防能力不足。因此,仔细进行的观察性研究
需要研究疫苗对这些疾病的益处。这些好处可能是一个令人信服的
接种疫苗的动机--犹豫不决。由于我们在流行病学方面的专业知识,
复杂的关系数据,熟悉数据集,我们可以有效地进行这项高影响力的工作。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CATHERINE KIM其他文献
CATHERINE KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CATHERINE KIM', 18)}}的其他基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Gestational diabetes and offspring aging and metabolism
妊娠期糖尿病与后代衰老和代谢
- 批准号:
10425757 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Gestational diabetes and offspring aging and metabolism
妊娠期糖尿病与后代衰老和代谢
- 批准号:
10577849 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
儿童疫苗对预防 1 型糖尿病、自身免疫性甲状腺疾病和乳糜泻的有益作用
- 批准号:
10367489 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
ReproEDIC: Risk and Progression of Reproductive Abnormalities in Type 1 Diabetes
ReproEDIC:1 型糖尿病生殖异常的风险和进展
- 批准号:
8477599 - 财政年份:2013
- 资助金额:
$ 19.5万 - 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
- 批准号:
7983696 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
- 批准号:
8098763 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
- 批准号:
8278068 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
A pilot lifestyle intervention for women with histories of GDM: The PEG Study
针对有 GDM 病史的女性的试点生活方式干预:PEG 研究
- 批准号:
7770845 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
A pilot lifestyle intervention for women with histories of GDM: The PEG Study
针对有 GDM 病史的女性的试点生活方式干预:PEG 研究
- 批准号:
7637097 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant














{{item.name}}会员




